Results 311 to 320 of about 3,530,803 (397)

Identification of plasminogen activator urokinase receptor-related non-coding RNA and immune prognostic signature for non-small cell lung cancer. [PDF]

Clinics (Sao Paulo)
Cheng Y, Bao S, Zhang H, Zhang Y, Li X, Li H, Jia X, Sun Q, Song Z.   +8 more
europepmc   +1 more source

Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation [PDF]

, 1989
Bontempo, FA, Kang, YG, Knot, EAR, Lewis, JH, Porte, RJ, Starzl, TE   +5 more
core  

Elucidating the Role and Mechanism of Alpha‐Enolase in Senescent Amelioration via Metabolic Reprogramming

Cell Proliferation, Volume 58, Issue 10, October 2025.
KB2764 interacted with alpha‐enolase (ENO1) and pyruvate kinase M (PKM), ultimately leading to PKM phosphorylation of ENO1. KB2764 consequently increased mitochondrial ATP production and decreased glycolysis dependence. Furthermore, the action of KB2764 extends its application to extend the lifespan of Caenorhabditis elegans.
Yun Haeng Lee, Hyunwoong Lim, Gyungmin Kim, Geonhee Jang, Myeong Uk Kuk, Ji Ho Park, Jee hee Yoon, Yoo Jin Lee, Duyeol Kim, Byeonghyeon So, Minseon Kim, Hyung Wook Kwon, Youngjoo Byun, Joon Tae Park   +13 more
wiley   +1 more source

Association Between Venous Mesenteric Thrombosis and Plasminogen Activator Inhibitor-1 Mutation. [PDF]

Cureus
Pereira V, Castanheira D, Sanches M, Castro Silva B, Almeida R.   +4 more
europepmc   +1 more source

Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids

Diabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5985-5995, October 2025.
Abstract Aims The aim of this study was to determine if retatrutide, a triple agonist of glucose‐dependent insulinotropic polypeptide (GIP) receptor, glucagon‐like peptide 1 (GLP‐1) receptor and glucagon (GCG) receptor, may lower serum triglyceride (TG) and low‐density lipoprotein cholesterol (LDL‐C) levels in part by decreasing circulating ...
Yi Wen, Deven Lemen, Yanzhu Lin, Yan Q. Chen, Ajit Regmi, William C. Roell, Melissa K. Thomas, Mark L. Hartman, Tamer Coskun, Zvonko Milicevic, Axel Haupt, Giacomo Ruotolo, Robert J. Konrad   +12 more
wiley   +1 more source

Loss of tissue-type plasminogen activator causes multiple developmental anomalies. [PDF]

Brain Commun
Uguen K, Frey T, Muthaffar O, Décarie JC, Ameziane N, Boissel S, Baradaran-Heravi Y, Rauch A, Oprea G, Rad A, Steindl K, Michaud JL.   +11 more
europepmc   +1 more source

Recombinant Plasminogen Activator of the Sandworm (Perinereis aibuhitensis) Expression in Escherichia coli. [PDF]

Bioengineering (Basel)
Song T, Diao X, Cheng J, Man Y, Chen B, Zhang H, Wu W.   +6 more
europepmc   +1 more source

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study. [PDF]

J Am Heart Assoc
Yadalam AK, Liu C, Sun YV, Mandawat A, Quyyumi AA, Hayek SS.   +5 more
europepmc   +1 more source

Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson's Disease. [PDF]

Med Princ Pract
Tanrikulu AM, Ozdilek B, Agirbasli M.
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Plasma Concentration Is Reduced Using Minimized Extracorporeal Circulation: Results of a Secondary Analysis of a Prospective Observational Study. [PDF]

J Clin Med
Zajonz TS, Edinger F, Götze J, Markmann M, Sander M, Koch C, Schneck E.   +6 more
europepmc   +1 more source